title: Additional phenytoin is frequently needed in patients undergoing craniotomy for supratentorial tumour.
authors.forename: M
authors.initials: M
authors.lastname: Radhakrishnan
authors.forename: N D
authors.initials: ND
authors.lastname: Devaraj
authors.forename: G S
authors.initials: GS
authors.lastname: Umamaheswara Rao
authors.forename: M N
authors.initials: MN
authors.lastname: Subhash
mesh_terms: D000328:Adult; D003399:Craniotomy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000008:administration & dosage* / Q000097:blood; D011183:Postoperative Complications / Q000097:blood / Q000517:prevention & control; D015173:Supratentorial Neoplasms / Q000188:drug therapy* / Q000601:surgery*
chemical_list: D010672:Phenytoin